SCHEMBL169629

SCHEMBL169629

C=C(C(=O)OCCN(C)C)C(Cl)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 4/20 0.56
LMNA P02545 5/20 0.51
CHRM2 P08172 3/20 0.51
CHRM3 P20309 2/20 0.51
SMN1; SMN2 Q16637 3/20 0.50
CYP1A2 P05177 2/20 0.46
CYP2D6 P10635 2/20 0.46
ADRA2A P08913 2/20 0.45
SLC6A2 P23975 2/20 0.45
SLC6A4 P31645 2/20 0.45
OPRM1 P35372 2/20 0.45
DRD3 P35462 2/20 0.45
SLC6A3 Q01959 2/20 0.45
HTR2A P28223 2/20 0.45
HRH1 P35367 2/20 0.45
CHRM4 P08173 1/20 0.45
CHRM5 P08912 1/20 0.45
TSHR P16473 1/20 0.45
ADRA2B P18089 1/20 0.45
HRH2 P25021 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL28164353 0.99 CHRM1 (0.54) CHRM1LMNACHRM2CHRM3SMN1; SMN2
SCHEMBL28529361 0.86 LMNA (0.64) CHRM1LMNACHRM2CHRM3SMN1; SMN2
SCHEMBL8070811 0.86 CHRM1 (0.45) CHRM1LMNACHRM2CHRM3SMN1; SMN2
SCHEMBL27075143 0.81 IDO1 (0.40) CHRM1LMNACHRM2CHRM3SMN1; SMN2
SCHEMBL10546414 0.81 CASP1 (0.55) LMNASMN1; SMN2CYP1A2CYP2D6TSHR
SCHEMBL28058990 0.80 CHRM1 (0.49) CHRM1LMNACHRM2CHRM3SMN1; SMN2
SCHEMBL11145864 0.78 CHRM1 (0.47) CHRM1LMNACHRM2CHRM3SMN1; SMN2
SCHEMBL128110 0.76 CHRM1 (0.50) CHRM1LMNACHRM2CHRM3SMN1; SMN2
SCHEMBL27533616 0.76 KMT2A (0.47) LMNASMN1; SMN2CYP1A2CYP2D6TSHR
SCHEMBL16789080 0.75 CHRM1 (0.62) CHRM1LMNACHRM2CHRM3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122070397-A Use of fast reverse cationic emulsion polymers with polyvinylamines as retention and drainage aids 凯米拉公司 2026-05-19 CN claimed
EP-4739418-A2 ONE-PASS DEOXYGENATION METHOD FOR POLYACRYLAMIDE PRODUCTION KEMIRA OYJ (FI) 2026-05-13 EP claimed
EP-4728136-A1 STRENGTH SYNERGY BETWEEN POLYMER AND PAPERMAKING STRENGTH AID Ecolab USA, Inc. (US) 2026-04-22 EP claimed
US-12600867-B2 Method of coating article, use for coating article, and polymerizable composition GC CORPORATION (JP) 2026-04-14 US claimed
EP-4716777-A2 USE OF AMPHOTERIC EMULSION POLYMERS WITH STRENGTH RESINS AS RETENTION AND DRAINAGE AIDS KEMIRA OYJ (FI) 2026-04-01 EP claimed
US-12553188-B2 GPAM compositions and methods KEMIRA OYJ (FI) 2026-02-17 US claimed
EP-4683950-A1 DUAL EMULSIFICATION OF ALKENYL SUCCINIC ANHYDRIDE TO IMPROVE SIZING PERFORMANCE AND STABILITY KEMIRA OYJ (FI) 2026-01-28 EP claimed
US-20250215649-A1 HIGH MOLECULAR WEIGHT GPAM WITH ANIONIC POLYSACCHARIDE PROMOTER KEMIRA OYJ (FI) 2025-07-03 US claimed
WO-2025088604-A1 COMPOSITION CONTAINING POLYELECTROLYTE SOLUTION AND POLYCATIONIC RHEOLOGY MODIFIER ADAMA AGAN LTD. (IL) 2025-05-01 WO claimed
US-20250137200-A1 HIGH MOLECULAR WEIGHT GPAM WITH ANIONIC POLYMERIC PROMOTER KEMIRA OYJ (FI) 2025-05-01 US claimed
US-5986030-A CATIONIC POLYMERS FROM ACRYLIC DERIVATIVE MONOMERS AND COPOLYMERS NALCO CHEMICAL COMPANY (US) 1999-11-16 US claimed
WO-1999020803-A1 POLYMERIC COMBINATIONS USED AS COPPER AND PRECIOUS METAL HEAP LEACHING AGGLOMERATION AIDS NALCO CHEMICAL COMPANY (US) 1999-04-29 WO claimed
WO-1998054234-A1 PREPARATION OF WATER SOLUBLE POLYMER DISPERSIONS FROM VINYLAMIDE MONOMERS NALCO CHEMICAL COMPANY (US) 1998-12-03 WO claimed
US-5833937-A AGGLOMERATING BY SEQUENTIAL ADDITION OF FIRST WATER SOLUBLE ANIONIC OR NONIONIC POLYMER AND SECOND CATIONIC WATER SOLUBLE POLYMER NALCO CHEMICAL COMPANY (US) 1998-11-10 US claimed
EP-0872497-A2 Fluorescent cationic monomers useful for tagging water soluble polymers NALCO CHEMICAL COMPANY (US) 1998-10-21 EP claimed
EP-0775165-A1 DADMAC/VINYL TRIALKOXYSILANE COPOLYMERS AND THEIR USE IN WASTEWATER TREATMENT NALCO CHEMICAL COMPANY (US) 1997-05-28 EP claimed
US-5595629-A CELLULOSE WITH CATIONIC AND ANIONIC POLYMERS, DRAINAGE TO FORM SHEETS AND DRYING NALCO CHEMICAL COMPANY (US) 1997-01-21 US claimed
WO-1996035731-A1 DADMAC/VINYL TRIALKOXYSILANE COPOLYMERS AND THEIR USE IN WASTEWATER TREATMENT NALCO CHEMICAL COMPANY (DE) 1996-11-14 WO claimed
US-5554298-A Steel mill flume water treatment NALCO CHEMICAL COMPANY (US) 1996-09-10 US claimed
US-5552498-A SURFACTANTS FOR DEMULSIFICATION BY MIXING WATER AND SODIUM HYDROXIDE, COOLING COPOLYMERIZATION ACRYLIC ACID AND AMINE ACRYLATES NALCO CHEMICAL COMPANY (US) 1996-09-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12600867-B2 Method of coating article, use for coating article, and polymerizable composition SARS1, SPIN1, ESPL1 CHRM1 479/4885LMNA 3803/4885CHRM2 1718/4885
US-12553188-B2 GPAM compositions and methods PGM2, SLC6A9, GNMT CHRM1 848/4885LMNA 565/4885CHRM2 680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.